
Top stories






Marketing & MediaEntries open for 702 Jozi My Jozi Walk the Talk 2026
Primedia Broadcasting 4 May 2026
More news










ESG & Sustainability
Migratory bird declines signal risks to water, food security, climate resilience







Sanofi-Aventis has told the U.S. Food and Drug Administration its rimonobant antiobesity drug, also sold under the Acomplia brand, brings a higher risk of suicidal thoughts than placebo, and it does not recommend the treatment for patients suffering from major depression.